L
Description
Biopharmaceutical CDMO established in 2022 by Lotte Group. Acquired Bristol Myers Squibb's Syracuse biologics manufacturing site in the US. Building Songdo Bio Campus in Incheon. Goal to become global Top 10 CDMO.